The current price of CNC is $69.68 — it has decreased by 6.05% since the previous close. Data as of Nov 6, 2026.
CNC is up 0.53% over the past week, up 7.85% over the past month and up 87.82% over the past year. The price is above its 200-day moving average of $55.85.
Analysts' average 12-month price target for CNC is $75.43, which implies 8.25% upside from the current price. Individual estimates range from $69.00 to $80.00.
Of the 21 analysts covering Centene Corp., 1 rates it a strong buy, 7 rate it a buy, 12 rate it a hold and 1 rates it a sell. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Centene Corp. has a market capitalization of $34.5B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Centene Corp. posted earnings of $0.58 per share against an estimate of $0.0957, beating expectations by 506.06%. Upcoming reports are listed in the earnings calendar.
Centene Corp. reported revenue of $50.65B in its most recent quarter, which has increased by 1.93% compared with the same quarter a year earlier. Analysts had expected $47.12B.
Centene Corp. has not paid any dividends over the past year.
Companies most comparable to Centene Corp. include UnitedHealth Group Incorporated, CVS Health Corp., Elevance Health Inc., Cigna Corporation and Humana Inc.
In the latest trading session CNC moved between $69.42 and $73.40, a range of 5.72% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Centene Corp. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Centene Corp. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks CNC has traded between $31.63 and $78.08. The current price is 10.76% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.